Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 58 (RPL7P58)

Target
RPL7P58
Molecular classification
Other
01

Overview

Ribosomal protein L7 pseudogene 58 (RPL7P58) is a non-coding, processed pseudogene of the RPL7 gene. It is an inactive genetic element formed from reverse transcription and integration of RPL7 mRNA; it does not yield a functional protein and is not involved in cellular or disease processes[1][3]. The canonical RPL7 gene encodes a ribosomal protein that forms part of the large 60S ribosomal subunit and is essential for protein synthesis, but pseudogene copies like RPL7P58 do not contribute to ribosomal structure or function[5][7]. Key points: - RPL7P58 is a pseudogene, not a protein, receptor, or enzyme[1][3]. - It is not considered a therapeutic or drug target[1][3]. - It does not encode any biological function, nor does it interact with drugs or act as a biomarker[1][3]. - No known aliases exist outside the standardized gene and pseudogene nomenclature[1][3]. - The gene family relates to ribosomal proteins, but pseudogenes are categorized as "other" [1][3]. - No documented disease roles, mechanisms, or safety concerns apply to this pseudogene[1][3].

02

Mechanism of action

Null

03

Biological functions

Other
04

Disease associations

Other

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 58 (RPL7P58).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 58 (RPL7P58).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call